Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4326
VirnetX Holding Corp
VHC
$65.8M
| $430K | ﹤0.01% |
4,620
+3,704
| +404% | +$252K |
|
4327
Equitable Holdings
EQH
$14.1B
| $429K | ﹤0.01% |
19,985
-475,376
| -96% | -$10.4M |
|
4328
Inovio Pharmaceuticals
INO
$93M
| $429K | ﹤0.01% |
6,425
+5,527
| +615% | +$308K |
|
|
GTS
4329
DELISTED
Triple-S Management Corporation
GTS
| $429K | ﹤0.01% |
23,931
-46,540
| -66% | -$1.23M |
|
|
MNDT
4330
CALL
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $428K | ﹤0.01% |
25,200
-3,900
| -13% | -$62.4K |
|
4331
Vanguard Total World Stock ETF
VT
$81.9B
| $427K | ﹤0.01% |
5,632
+1,137
| +25% | +$85.6K |
|
|
KEG
4332
DELISTED
Key Energy Services, Inc. Common Stock
KEG
| $427K | ﹤0.01% |
37,230
+459
| +1% | +$6.71K |
|
4333
PUT
Beazer Homes USA
BZH
$874M
| $426K | ﹤0.01% |
40,600
+29,700
| +272% | +$391K |
|
4334
CALL
Fossil Group
FOSL
$330M
| $426K | ﹤0.01% |
18,300
-7,100
| -28% | -$179K |
|
4335
CALL
Paylocity
PCTY
$8.1B
| $426K | ﹤0.01% |
5,300
+2,800
| +112% | +$198K |
|
|
SAGE
4336
CALL
DELISTED
Sage Therapeutics
SAGE
| $424K | ﹤0.01% |
3,000
+600
| +25% | +$92.6K |
|
4337
PUT
Ecolab
ECL
$78.1B
| $423K | ﹤0.01% |
2,700
-200
| -7% | -$29.7K |
|
|
BRSL
4338
PUT
Brightstar Lottery PLC
BRSL
$2.15B
| $423K | ﹤0.01% |
21,400
+13,800
| +182% | +$301K |
|
4339
The RMR Group
RMR
$337M
| $423K | ﹤0.01% |
4,551
+2,755
| +153% | +$242K |
|
|
CVRR
4340
DELISTED
CVR Refining, LP
CVRR
| $423K | ﹤0.01% |
21,488
-49,225
| -70% | -$1.04M |
|
|
CHU
4341
DELISTED
China Unicom (HONG KONG) Limited
CHU
| $423K | ﹤0.01% |
36,176
+12,176
| +51% | +$146K |
|
4342
CALL
Sturm, Ruger & Co
RGR
$600M
| $421K | ﹤0.01% |
6,100
+1,000
| +20% | +$60.5K |
|
|
BITA
4343
PUT
DELISTED
Bitauto Holdings Limited
BITA
| $421K | ﹤0.01% |
18,300
-25,000
| -58% | -$571K |
|
|
PRMW
4344
DELISTED
Primo Water Corporation
PRMW
| $421K | ﹤0.01% |
23,287
+7,865
| +51% | +$146K |
|
4345
PUT
Oneok
OKE
$58.3B
| $420K | ﹤0.01% |
6,200
-4,900
| -44% | -$335K |
|
4346
Calix
CALX
$2.51B
| $419K | ﹤0.01% |
51,737
+6,405
| +14% | +$48.9K |
|
|
DHIL
4347
DELISTED
Diamond Hill
DHIL
| $419K | ﹤0.01% |
2,535
+1,995
| +369% | +$368K |
|
4348
Novavax
NVAX
$1.34B
| $419K | ﹤0.01% |
11,123
+8,429
| +313% | +$237K |
|
|
ADVM
4349
DELISTED
Adverum Biotechnologies
ADVM
| $418K | ﹤0.01% |
6,914
+4,698
| +212% | +$264K |
|
4350
Prothena Corp
PRTA
$475M
| $418K | ﹤0.01% |
31,937
+28,624
| +864% | +$413K |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.